Synthetic Biologics, Inc.
Synthetic Biologics, Inc. (SYN) Stock Overview
Explore Synthetic Biologics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
16.2M
P/E Ratio
-0.11
EPS (TTM)
$-0.12
ROE
-1.26%
SYN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Synthetic Biologics, Inc. (SYN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.55.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.11 and a market capitalization of 16.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.